Clinical Trials and Research Programs
Doylestown
Health is currently enrolling patients in the following approved oncology
protocols:
Doylestown
Health is currently enrolling patients in the following approved oncology
protocols:
Cancer Experience Registry Survey is about your cancer experience. Allows our Cancer Institute to continually enhance our design of support services, effective policy and impactful research www.cancerexperienceregistry.org/join/DH
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node Negative, Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with >/= 1cm Residual Invasive Cancer of Positive Lymph Nosed After Neoadjuvant Chemotherapy*
Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored With Serum Tumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients with Metastatic Hormone Receptor Positive Breast Cancer*
Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men with Advanced Prostate Cancer
PROmoting Prostate Cancer Engagement and Learning: Feasibility of Digital Health Coaching for Men with Prostate Cancer
Phase II/III Study of Circulating tumOr DNA as a Predictive BiomaRker in Adjuvant Chemotherapy in Patients with Stage IIA colon Cancer (COBRA)
Integration of Immunotherapy into Adjuvant Therapy for Resected NSCLC: ALCHEMIST I-O
Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) Versus Observation*
National Cancer Institute – Molecular Analysis for Therapy Choice
Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for Your (TAPISTRY) Phase II Platform Trial
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
For more information about Doylestown Health's open cancer trials visit the U.S. National Institutes of Health's Clinical Trials database.